If you’re interested in registering your business to gain access to wholesale pricing, apply now click here!Wholesale pricing: apply here
Need help? Text us and our team of experts will reply in minutesQuestions? Text +1 (833) 761-4929
FOR LABORATORY AND RESEARCH USE ONLY · NOT FOR HUMAN CONSUMPTION
IGF-1 LR3 1MG 1mg research vial
1 / 3

IGF-1LR3

IGF-1 LR3 1MG

$96.99

In stock

Ships from our California, USA facility

Batch documentation

Latest Certificate of Analysis

Lot: IGF1260821-B-L1mgPremier Analytical SciencesTested Sep 14, 2026

Buy more, save more

All sizes of this product count toward your quantity. Can’t be combined with coupon codes; your cart applies whichever saves you more.

Quantity
1
For Laboratory and Research Use Only

Not for human consumption. This product is not a drug, food, or cosmetic, and is sold only to qualified researchers and licensed laboratories. By purchasing, the buyer agrees to use it in compliance with all applicable laws.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Product Overview

IGF-1 LR3 1MG Research Peptide

IGF-1 LR3 1MG is a research peptide referenced in scientific literature as a synthetic analogue of insulin-like growth factor 1. This IGF-1 LR3 1MG product page provides educational, research-only information focused on compound structure, laboratory context, and non-clinical investigation.

Some peptides, including IGF-1 LR3, are synthetically created and can be derived from natural products, often designed as a combination of specific amino acid sequences to achieve targeted biological effects.

IGF-1 LR3 1MG is supplied by NuRev Peptides strictly for laboratory research and testing purposes. NuRev Peptides is a US-based supplier of high-purity research peptides primarily for laboratory use. All information presented here is neutral, factual, and intended to support scientific discussion rather than clinical, therapeutic, or diagnostic application. This compound is not intended for human or animal use.

NuRev Peptides is committed to quality and research integrity. Every batch is tested by independent third-party laboratories to ensure it exceeds 99% purity, and all products are produced in FDA-audited, cGMP-certified facilities. Each order includes a Certificate of Analysis (CoA) detailing product identity, method, and purity.

Scientific Background of IGF-1 LR3 1MG Peptides

IGF-1 LR3 1MG is structurally modified from native IGF-1 through an arginine substitution at position 3 and a 13–amino acid extension at the N-terminus. These modifications are discussed in research literature for their effect on reducing binding affinity to insulin-like growth factor binding proteins, resulting in extended biological half-life in experimental models.

In non-clinical research environments, IGF-1 LR3 is studied in relation to cellular growth signaling, anabolic pathway exploration, and metabolic signaling frameworks. Research discussions focus on receptor interaction dynamics, intracellular signaling cascades, and molecular behavior under controlled laboratory conditions. NuRev Peptides does not make claims regarding outcomes, efficacy, or safety related to this compound.

All information on this page is provided strictly for educational and research discussion purposes. This compound is not intended for diagnostic, therapeutic, medical, or veterinary use under any circumstances.

NuRev Peptides maintains a research-only policy and emphasizes transparency, documentation, and third-party laboratory verification where applicable.

Research-Only Use and Compliance Notice

Additional scientific context related to compounds can be found through publicly available research databases such as PubChem.

For further information on purity please visit Certificates of Analysis.

To learn more about our research disclaimers please visit our page Research-only disclaimer.

Product Name
IGF-1 LR3 1MG
CAS Number
946870-92-4, 143045-27-6
Molecular Formula
C400H625N111O115S9
Molecular Weight
9117.60 g/mol
Form
Lyophilized powder
Purity
≥99% by HPLC, verified by independent third-party testing; see the batch Certificate of Analysis
Storage
Store sealed at −20 °C, dry and protected from light; 2–8 °C for short periods. Ships at ambient temperature
Product Information

Product Overview

IGF-1 LR3 1MG Research Peptide

IGF-1 LR3 1MG is a research peptide referenced in scientific literature as a synthetic analogue of insulin-like growth factor 1. This IGF-1 LR3 1MG product page provides educational, research-only information focused on compound structure, laboratory context, and non-clinical investigation.

Some peptides, including IGF-1 LR3, are synthetically created and can be derived from natural products, often designed as a combination of specific amino acid sequences to achieve targeted biological effects.

IGF-1 LR3 1MG is supplied by NuRev Peptides strictly for laboratory research and testing purposes. NuRev Peptides is a US-based supplier of high-purity research peptides primarily for laboratory use. All information presented here is neutral, factual, and intended to support scientific discussion rather than clinical, therapeutic, or diagnostic application. This compound is not intended for human or animal use.

NuRev Peptides is committed to quality and research integrity. Every batch is tested by independent third-party laboratories to ensure it exceeds 99% purity, and all products are produced in FDA-audited, cGMP-certified facilities. Each order includes a Certificate of Analysis (CoA) detailing product identity, method, and purity.

Scientific Background of IGF-1 LR3 1MG Peptides

IGF-1 LR3 1MG is structurally modified from native IGF-1 through an arginine substitution at position 3 and a 13–amino acid extension at the N-terminus. These modifications are discussed in research literature for their effect on reducing binding affinity to insulin-like growth factor binding proteins, resulting in extended biological half-life in experimental models.

In non-clinical research environments, IGF-1 LR3 is studied in relation to cellular growth signaling, anabolic pathway exploration, and metabolic signaling frameworks. Research discussions focus on receptor interaction dynamics, intracellular signaling cascades, and molecular behavior under controlled laboratory conditions. NuRev Peptides does not make claims regarding outcomes, efficacy, or safety related to this compound.

All information on this page is provided strictly for educational and research discussion purposes. This compound is not intended for diagnostic, therapeutic, medical, or veterinary use under any circumstances.

NuRev Peptides maintains a research-only policy and emphasizes transparency, documentation, and third-party laboratory verification where applicable.

Research-Only Use and Compliance Notice

Additional scientific context related to compounds can be found through publicly available research databases such as PubChem.

For further information on purity please visit Certificates of Analysis.

To learn more about our research disclaimers please visit our page Research-only disclaimer.

Product Name
IGF-1 LR3 1MG
CAS Number
946870-92-4, 143045-27-6
Molecular Formula
C400H625N111O115S9
Molecular Weight
9117.60 g/mol
Form
Lyophilized powder
Purity
≥99% by HPLC, verified by independent third-party testing; see the batch Certificate of Analysis
Storage
Store sealed at −20 °C, dry and protected from light; 2–8 °C for short periods. Ships at ambient temperature
Specifications
Available sizes
1mg
CAS Number
946870-92-4, 143045-27-6
Molecular Formula
C400H625N111O115S9
Molecular Weight
9117.60 g/mol
Form
Lyophilized powder
Purity
≥99% by HPLC, verified by independent third-party testing; see the batch Certificate of Analysis
Storage
Store sealed at −20 °C, dry and protected from light; 2–8 °C for short periods. Ships at ambient temperature
Batch Documentation
LotSizeTestTestedLabDocument
IGF1260821-B-L1mgPurity & identitySep 14, 2026Premier Analytical SciencesView COA →
DPS-33562801mgPurity & identityJul 24, 2026Horizon AnalyticalView COA →
DPS-33562801mgEndotoxinJul 24, 2026Horizon AnalyticalView COA →